Target intelligence / Profile preview

Hepatitis C virus non-structural protein NS4A (NS4A)

Target
NS4A
Molecular classification
Enzyme cofactor, Viral protein, Serine protease cofactor
01

Overview

Hepatitis C virus non-structural protein NS4A (NS4A) is a small, 54-amino-acid polypeptide that serves as an essential cofactor for the NS3 serine protease [1.1.1, 1.3.1]. Together, they form the NS3-NS4A complex, which is responsible for the proteolytic processing of the HCV polyprotein into functional units required for viral replication [1.1.2, 1.3.3]. Beyond its role in proteolysis, NS4A anchors the NS3-NS4A complex to the endoplasmic reticulum (ER) and mitochondrial membranes, enhances NS3 helicase activity, and regulates NS5A phosphorylation [1.2.1, 1.3.2]. The NS3-NS4A complex also plays a critical role in immune evasion by cleaving host proteins like MAVS and TRIF, thereby disrupting interferon signaling [1.3.3]. Due to its central role in the viral life cycle, the NS3-NS4A complex is a primary target for Direct-Acting Antivirals (DAAs), specifically NS3/4A protease inhibitors such as glecaprevir and voxilaprevir [1.3.3, 1.3.4]. These drugs bind to the protease active site or the NS3-NS4A interface, effectively halting viral replication and leading to high rates of sustained virologic response in patients with chronic hepatitis C [1.1.1, 1.3.4].

Other names
NS4Ap8Non-structural protein 4ANS3-NS4A cofactorHCV NS4A
02

Mechanism of action

Inhibition of the NS3-NS4A serine protease complex, preventing the cleavage of the viral polyprotein into functional non-structural proteins, thereby halting viral replication.

03

Biological functions

Viral replicationProteolysisMembrane anchoringImmune evasionViral assembly
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Drug resistanceDrug-drug interactionsHepatic impairmentHepatitis B virus reactivation
06

Interacting drugs

Boceprevir

8 more in the full profile.

07

Biomarkers

HCV RNA levelsSustained virologic response (SVR)Resistance-associated substitutions (RASs)

Beyond the preview

Go deeper on Hepatitis C virus non-structural protein NS4A (NS4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus non-structural protein NS4A (NS4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call